According to the reports, the CTSB recombinant protein market size is projected to grow from $132.4 billion in 2023 to $203.6 billion in 2029 at a CAGR of 7.5%. With this growth, the market expands, and researchers are increasingly using CTSB recombinant proteins for different applications in disease research, particularly cancer, Alzheimer’s, and cardiac conditions.Â
However, despite of its…